Agree with you 1~Eye~Jack!!... The revenue potential here for RGBP is phenomenal and a very positive indicator within the 10-K highlights! How much could we see from a big pharma deal for HemaXellerate alone... $500,000,000 or more! Just for one breakthrough orphan drug treatment! ;-)